We are discussing AlphaChip in 2024, not AlphaGo from 2016. I don't know much about protein folding (there were some controversies there, but that's not relevant). Neither of these has been related to product claims.
As for "nobody can re-produce", no, that's not the definition. Imaginary things are not competitive advantage. They are exaggerating, and that's bad. But yeah, that's what companies do, you are right.
As for "nobody can re-produce", no, that's not the definition. Imaginary things are not competitive advantage. They are exaggerating, and that's bad. But yeah, that's what companies do, you are right.